메뉴 건너뛰기




Volumn 3, Issue 9, 2015, Pages 1017-1029

Resistance to antiangiogenic therapy is associated with an immunosuppressive tumor microenvironment in metastatic Renal cell carcinoma

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; PROGRAMMED DEATH 1 LIGAND 1; SUNITINIB; TRANSCRIPTION FACTOR FOXP3; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; BEVACIZUMAB; CD274 PROTEIN, HUMAN; INDOLE DERIVATIVE; PYRROLE DERIVATIVE; TUMOR MARKER;

EID: 84962013731     PISSN: 23266066     EISSN: 23266074     Source Type: Journal    
DOI: 10.1158/2326-6066.CIR-14-0244     Document Type: Article
Times cited : (161)

References (46)
  • 1
    • 84858800620 scopus 로고    scopus 로고
    • The immune contexture in human tumours: Impact on clinical outcome
    • Fridman WH, Pages F, Sautes-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 2012;12:298-306.
    • (2012) Nat Rev Cancer , vol.12 , pp. 298-306
    • Fridman, W.H.1    Pages, F.2    Sautes-Fridman, C.3    Galon, J.4
  • 2
    • 0035394233 scopus 로고    scopus 로고
    • Proliferative activity of intratumoral CD8 (+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: Clinicopathologic demonstration of antitumor immunity
    • Nakano O, Sato M, Naito Y, Suzuki K, Orikasa S, Aizawa M, et al. Proliferative activity of intratumoral CD8 (+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity. Cancer Res 2001;61:5132-6.
    • (2001) Cancer Res , vol.61 , pp. 5132-5136
    • Nakano, O.1    Sato, M.2    Naito, Y.3    Suzuki, K.4    Orikasa, S.5    Aizawa, M.6
  • 3
    • 0346752520 scopus 로고    scopus 로고
    • The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer
    • Bromwich EJ, McArdle PA, Canna K, McMillan DC, McNicol AM, Brown M, et al. The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer. Br J Cancer 2003;89:1906-8.
    • (2003) Br J Cancer , vol.89 , pp. 1906-1908
    • Bromwich, E.J.1    McArdle, P.A.2    Canna, K.3    McMillan, D.C.4    McNicol, A.M.5    Brown, M.6
  • 5
    • 61349100687 scopus 로고    scopus 로고
    • Myeloid-derived suppressor cells as regulators of the immune system
    • Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009;9:162-74.
    • (2009) Nat Rev Immunol , vol.9 , pp. 162-174
    • Gabrilovich, D.I.1    Nagaraj, S.2
  • 6
    • 84858766182 scopus 로고    scopus 로고
    • The blockade of immune checkpoints in cancer immunotherapy
    • Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 2012;12:252-64.
    • (2012) Nat Rev Cancer , vol.12 , pp. 252-264
    • Pardoll, D.M.1
  • 8
    • 33846164111 scopus 로고    scopus 로고
    • Renal-cell carcinoma-molecular pathways and therapies
    • Brugarolas J. Renal-cell carcinoma-molecular pathways and therapies. N Engl J Med 2007;356:185-7.
    • (2007) N Engl J Med , vol.356 , pp. 185-187
    • Brugarolas, J.1
  • 10
    • 84894650643 scopus 로고    scopus 로고
    • Potential of new therapies like anti-PD1 in kidney cancer
    • Gunturi A, McDermott DF. Potential of new therapies like anti-PD1 in kidney cancer. Curr Treat Options Oncol 2014;15:137-46.
    • (2014) Curr Treat Options Oncol , vol.15 , pp. 137-146
    • Gunturi, A.1    McDermott, D.F.2
  • 11
    • 84908405833 scopus 로고    scopus 로고
    • The future of cancer therapy: Selecting patients likely to respond to PD1/L1 blockade
    • Ribas A, Tumeh PC. The Future of Cancer Therapy: Selecting Patients Likely to Respond to PD1/L1 Blockade. Clin Cancer Res 2014;20:4982-4.
    • (2014) Clin Cancer Res , vol.20 , pp. 4982-4984
    • Ribas, A.1    Tumeh, P.C.2
  • 13
    • 84923078390 scopus 로고    scopus 로고
    • MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
    • Powles T, Eder JP, Fine GD, Braiteh FS, Loriot Y, Cruz C, et al. MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer. Nature 2014;515:558-62.
    • (2014) Nature , vol.515 , pp. 558-562
    • Powles, T.1    Eder, J.P.2    Fine, G.D.3    Braiteh, F.S.4    Loriot, Y.5    Cruz, C.6
  • 14
    • 84920956735 scopus 로고    scopus 로고
    • Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
    • Herbst RS, Soria JC, Kowanetz M, Fine GD, Hamid O, Gordon MS, et al. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients. Nature 2014;515:563-7.
    • (2014) Nature , vol.515 , pp. 563-567
    • Herbst, R.S.1    Soria, J.C.2    Kowanetz, M.3    Fine, G.D.4    Hamid, O.5    Gordon, M.S.6
  • 15
    • 84861743338 scopus 로고    scopus 로고
    • Transient aggregation of ubiquitinated proteins is a cytosolic unfolded protein response to inflammation and endoplasmic reticulum stress
    • Liu XD, Ko S, Xu Y, Fattah EA, Xiang Q, Jagannath C, et al. Transient aggregation of ubiquitinated proteins is a cytosolic unfolded protein response to inflammation and endoplasmic reticulum stress. J Biol Chem 2012;287:19687-98.
    • (2012) J Biol Chem , vol.287 , pp. 19687-19698
    • Liu, X.D.1    Ko, S.2    Xu, Y.3    Fattah, E.A.4    Xiang, Q.5    Jagannath, C.6
  • 16
    • 58849158826 scopus 로고    scopus 로고
    • Cytoplasmic sequestration of p27 via AKT phosphorylation in renal cell carcinoma
    • Kim J, Jonasch E, Alexander A, Short JD, Cai S, Wen S, et al. Cytoplasmic sequestration of p27 via AKT phosphorylation in renal cell carcinoma. Clin Cancer Res 2009;15:81-90.
    • (2009) Clin Cancer Res , vol.15 , pp. 81-90
    • Kim, J.1    Jonasch, E.2    Alexander, A.3    Short, J.D.4    Cai, S.5    Wen, S.6
  • 17
    • 84937974295 scopus 로고    scopus 로고
    • Autophagy mediates HIF2a degradation and suppresses renal tumorigenesis
    • Liu XD, Yao J, Tripathi DN, Ding Z, Xu Y, Sun M, et al. Autophagy mediates HIF2a degradation and suppresses renal tumorigenesis. Oncogene 2015;34:2450-60.
    • (2015) Oncogene , vol.34 , pp. 2450-2460
    • Liu, X.D.1    Yao, J.2    Tripathi, D.N.3    Ding, Z.4    Xu, Y.5    Sun, M.6
  • 18
    • 77950339501 scopus 로고    scopus 로고
    • Vascular endothelial growth factor targeted therapy in the perioperative setting: Implications for patient care
    • Bose D, Meric-Bernstam F, Hofstetter W, Reardon DA, Flaherty KT, Ellis LM. Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care. Lancet Oncol 2010;11:373-82.
    • (2010) Lancet Oncol , vol.11 , pp. 373-382
    • Bose, D.1    Meric-Bernstam, F.2    Hofstetter, W.3    Reardon, D.A.4    Flaherty, K.T.5    Ellis, L.M.6
  • 19
    • 33745851479 scopus 로고    scopus 로고
    • CTLA4 blockade and GMCSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells
    • Quezada SA, Peggs KS, Curran MA, Allison JP. CTLA4 blockade and GMCSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells. J Clin Invest 2006;116:1935-45.
    • (2006) J Clin Invest , vol.116 , pp. 1935-1945
    • Quezada, S.A.1    Peggs, K.S.2    Curran, M.A.3    Allison, J.P.4
  • 20
    • 54449091476 scopus 로고    scopus 로고
    • CTLA-4 blockade increases IFNgamma-producing CD4+ICOShi cells to shift the ratio of effector to regulatory T cells in cancer patients
    • Liakou CI, Kamat A, Tang DN, Chen H, Sun J, Troncoso P, et al. CTLA-4 blockade increases IFNgamma-producing CD4+ICOShi cells to shift the ratio of effector to regulatory T cells in cancer patients. Proc Natl Acad Sci U S A 2008;105:14987-92.
    • (2008) Proc Natl Acad Sci U S A , vol.105 , pp. 14987-14992
    • Liakou, C.I.1    Kamat, A.2    Tang, D.N.3    Chen, H.4    Sun, J.5    Troncoso, P.6
  • 21
    • 84883863501 scopus 로고    scopus 로고
    • Upregulation of PD-L1, IDO, and T (regs) in the melanoma tumor microenvironment is driven by CD8 (+) T cells
    • Spranger S, Spaapen RM, Zha Y, Williams J, Meng Y, Ha TT, et al. Upregulation of PD-L1, IDO, and T (regs) in the melanoma tumor microenvironment is driven by CD8 (+) T cells. Sci Transl Med 2013;5:200ra116.
    • (2013) Sci Transl Med , vol.5 , pp. 200ra116
    • Spranger, S.1    Spaapen, R.M.2    Zha, Y.3    Williams, J.4    Meng, Y.5    Ha, T.T.6
  • 22
    • 84859128199 scopus 로고    scopus 로고
    • Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape
    • Taube JM, Anders RA, Young GD, Xu H, Sharma R, McMiller TL, et al. Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape. Sci Transl Med 2012;4:127ra137.
    • (2012) Sci Transl Med , vol.4 , pp. 127ra137
    • Taube, J.M.1    Anders, R.A.2    Young, G.D.3    Xu, H.4    Sharma, R.5    McMiller, T.L.6
  • 23
    • 33947233249 scopus 로고    scopus 로고
    • Maternal acceptance of the fetus: True human tolerance
    • Guleria I, Sayegh MH. Maternal acceptance of the fetus: true human tolerance. J Immunol 2007;178:3345-51.
    • (2007) J Immunol , vol.178 , pp. 3345-3351
    • Guleria, I.1    Sayegh, M.H.2
  • 24
    • 10344220548 scopus 로고    scopus 로고
    • Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target
    • Thompson RH, Gillett MD, Cheville JC, Lohse CM, Dong H, Webster WS, et al. Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target. Proc Natl Acad Sci U S A 2004;101:17174-9.
    • (2004) Proc Natl Acad Sci U S A , vol.101 , pp. 17174-17179
    • Thompson, R.H.1    Gillett, M.D.2    Cheville, J.C.3    Lohse, C.M.4    Dong, H.5    Webster, W.S.6
  • 25
    • 84890258463 scopus 로고    scopus 로고
    • Autotaxin-lysophosphatidic acid signaling axis mediates tumorigenesis and development of acquired resistance to sunitinib in renal cell carcinoma
    • Su SC, Hu X, Kenney PA, Merrill MM, Babaian KN, Zhang XY, et al. Autotaxin-lysophosphatidic acid signaling axis mediates tumorigenesis and development of acquired resistance to sunitinib in renal cell carcinoma. Clin Cancer Res 2013;19:6461-72.
    • (2013) Clin Cancer Res , vol.19 , pp. 6461-6472
    • Su, S.C.1    Hu, X.2    Kenney, P.A.3    Merrill, M.M.4    Babaian, K.N.5    Zhang, X.Y.6
  • 26
    • 84899753178 scopus 로고    scopus 로고
    • PD-L1 is a novel direct target of HIF-1a, and its blockade under hypoxia enhanced MDSC-mediated T cell activation
    • Noman MZ, Desantis G, Janji B, Hasmim M, Karray S, Dessen P, et al. PD-L1 is a novel direct target of HIF-1a, and its blockade under hypoxia enhanced MDSC-mediated T cell activation. J Exp Med 2014;211:781-90.
    • (2014) J Exp Med , vol.211 , pp. 781-790
    • Noman, M.Z.1    Desantis, G.2    Janji, B.3    Hasmim, M.4    Karray, S.5    Dessen, P.6
  • 27
    • 79956045735 scopus 로고    scopus 로고
    • Enhancement of T-cell-mediated antitumor response: Angiostatic adjuvant to immunotherapy against cancer
    • Dings RP, Vang KB, Castermans K, Popescu F, Zhang Y, Oude Egbrink MG, et al. Enhancement of T-cell-mediated antitumor response: angiostatic adjuvant to immunotherapy against cancer. Clin Cancer Res 2011;17:3134-45.
    • (2011) Clin Cancer Res , vol.17 , pp. 3134-3145
    • Dings, R.P.1    Vang, K.B.2    Castermans, K.3    Popescu, F.4    Zhang, Y.5    Oude Egbrink, M.G.6
  • 28
    • 84857506147 scopus 로고    scopus 로고
    • Consequence of dose scheduling of sunitinib on host immune response elements and vaccine combination therapy
    • Farsaci B, Higgins JP, Hodge JW. Consequence of dose scheduling of sunitinib on host immune response elements and vaccine combination therapy. Int J Cancer 2012;130:1948-59.
    • (2012) Int J Cancer , vol.130 , pp. 1948-1959
    • Farsaci, B.1    Higgins, J.P.2    Hodge, J.W.3
  • 29
    • 33646231504 scopus 로고    scopus 로고
    • Anti-angiogenesis therapy can overcome endothelial cell anergy and promote leukocyte-endothelium interactions and infiltration in tumors
    • Dirkx AE, oude Egbrink MG, Castermans K, van der Schaft DW, Thijssen VL, Dings RP, et al. Anti-angiogenesis therapy can overcome endothelial cell anergy and promote leukocyte-endothelium interactions and infiltration in tumors. FASEB J 2006;20:621-30.
    • (2006) FASEB J , vol.20 , pp. 621-630
    • Dirkx, A.E.1    Oude Egbrink, M.G.2    Castermans, K.3    Van Der Schaft, D.W.4    Thijssen, V.L.5    Dings, R.P.6
  • 30
    • 84891094512 scopus 로고    scopus 로고
    • Ways to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytes
    • Bellone M, Calcinotto A. Ways to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytes. Front Oncol 2013;3:231.
    • (2013) Front Oncol , vol.3 , pp. 231
    • Bellone, M.1    Calcinotto, A.2
  • 31
    • 83755181759 scopus 로고    scopus 로고
    • Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice
    • Michaud M, Martins I, Sukkurwala AQ, Adjemian S, Ma Y, Pellegatti P, et al. Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science 2011;334:1573-7.
    • (2011) Science , vol.334 , pp. 1573-1577
    • Michaud, M.1    Martins, I.2    Sukkurwala, A.Q.3    Adjemian, S.4    Ma, Y.5    Pellegatti, P.6
  • 32
    • 0029943319 scopus 로고    scopus 로고
    • Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium
    • Griffioen AW, Damen CA, Blijham GH, Groenewegen G. Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium. Blood 1996;88:667-73.
    • (1996) Blood , vol.88 , pp. 667-673
    • Griffioen, A.W.1    Damen, C.A.2    Blijham, G.H.3    Groenewegen, G.4
  • 33
    • 0030044629 scopus 로고    scopus 로고
    • Endothelial intercellular adhesion molecule-1 expression is suppressed in human malignancies: The role of angiogenic factors
    • Griffioen AW, Damen CA, Martinotti S, Blijham GH, Groenewegen G. Endothelial intercellular adhesion molecule-1 expression is suppressed in human malignancies: the role of angiogenic factors. Cancer Res 1996;56:1111-7.
    • (1996) Cancer Res , vol.56 , pp. 1111-1117
    • Griffioen, A.W.1    Damen, C.A.2    Martinotti, S.3    Blijham, G.H.4    Groenewegen, G.5
  • 34
    • 80054098093 scopus 로고    scopus 로고
    • Sunitinib facilitates the activation and recruitment of therapeutic anti-tumor immunity in concert with specific vaccination
    • Bose A, Taylor JL, Alber S, Watkins SC, Garcia JA, Rini BI, et al. Sunitinib facilitates the activation and recruitment of therapeutic anti-tumor immunity in concert with specific vaccination. Int J Cancer 2011;129:2158-70.
    • (2011) Int J Cancer , vol.129 , pp. 2158-2170
    • Bose, A.1    Taylor, J.L.2    Alber, S.3    Watkins, S.C.4    Garcia, J.A.5    Rini, B.I.6
  • 35
    • 77956396096 scopus 로고    scopus 로고
    • Autophagy plays an important role in sunitinib-mediated cell death in H9c2 cardiac muscle cells
    • Zhao Y, Xue T, Yang X, Zhu H, Ding X, Lou L, et al. Autophagy plays an important role in sunitinib-mediated cell death in H9c2 cardiac muscle cells. Toxicol Appl Pharmacol 2010;248:20-7.
    • (2010) Toxicol Appl Pharmacol , vol.248 , pp. 20-27
    • Zhao, Y.1    Xue, T.2    Yang, X.3    Zhu, H.4    Ding, X.5    Lou, L.6
  • 36
    • 84879605085 scopus 로고    scopus 로고
    • Inhibition of autophagy enhances anticancer effects of bevacizumab in hepatocarcinoma
    • Guo XL, Li D, Sun K, Wang J, Liu Y, Song JR, et al. Inhibition of autophagy enhances anticancer effects of bevacizumab in hepatocarcinoma. J Mol Med (Berl) 2013;91:473-83.
    • (2013) J Mol Med (Berl) , vol.91 , pp. 473-483
    • Guo, X.L.1    Li, D.2    Sun, K.3    Wang, J.4    Liu, Y.5    Song, J.R.6
  • 37
    • 84928705533 scopus 로고    scopus 로고
    • VEGF suppresses T-lymphocyte infiltration in the tumor microenvironment through inhibition of NF-kB-induced endothelial activation
    • Huang H, Langenkamp E, Georganaki M, Loskog A, Fuchs PF, Dieterich LC, et al. VEGF suppresses T-lymphocyte infiltration in the tumor microenvironment through inhibition of NF-kB-induced endothelial activation. FASEB J 2015;29:227-38.
    • (2015) FASEB J , vol.29 , pp. 227-238
    • Huang, H.1    Langenkamp, E.2    Georganaki, M.3    Loskog, A.4    Fuchs, P.F.5    Dieterich, L.C.6
  • 38
    • 84898797252 scopus 로고    scopus 로고
    • Activation of vascular endothelial growth factor receptor-3 in macrophages restrains TLR4-NFkappaB signaling and protects against endotoxin shock
    • Zhang Y, Lu Y, Ma L, Cao X, Xiao J, Chen J, et al. Activation of vascular endothelial growth factor receptor-3 in macrophages restrains TLR4-NFkappaB signaling and protects against endotoxin shock. Immunity 2014;40:501-14.
    • (2014) Immunity , vol.40 , pp. 501-514
    • Zhang, Y.1    Lu, Y.2    Ma, L.3    Cao, X.4    Xiao, J.5    Chen, J.6
  • 39
    • 68949145218 scopus 로고    scopus 로고
    • Overall survival and updated results for sunitinib compared with interferon alfa in patientswith metastatic renal cell carcinoma
    • Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Oudard S, et al. Overall survival and updated results for sunitinib compared with interferon alfa in patientswith metastatic renal cell carcinoma. JClin Oncol 2009;27:3584-90.
    • (2009) JClin Oncol , vol.27 , pp. 3584-3590
    • Motzer, R.J.1    Hutson, T.E.2    Tomczak, P.3    Michaelson, M.D.4    Bukowski, R.M.5    Oudard, S.6
  • 40
    • 65549141834 scopus 로고    scopus 로고
    • The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies
    • Ozao-Choy J, Ma G, Kao J, Wang GX, Meseck M, Sung M, et al. The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies. Cancer Res 2009;69:2514-22.
    • (2009) Cancer Res , vol.69 , pp. 2514-2522
    • Ozao-Choy, J.1    Ma, G.2    Kao, J.3    Wang, G.X.4    Meseck, M.5    Sung, M.6
  • 41
    • 77957327205 scopus 로고    scopus 로고
    • Targeting Stat3 in the myeloid compartment drastically improves the in vivo antitumor functions of adoptively transferred T cells
    • Herrmann A, Kortylewski M, Kujawski M, Zhang C, Reckamp K, Armstrong B, et al. Targeting Stat3 in the myeloid compartment drastically improves the in vivo antitumor functions of adoptively transferred T cells. Cancer Res 2010;70:7455-64.
    • (2010) Cancer Res , vol.70 , pp. 7455-7464
    • Herrmann, A.1    Kortylewski, M.2    Kujawski, M.3    Zhang, C.4    Reckamp, K.5    Armstrong, B.6
  • 42
    • 84886945385 scopus 로고    scopus 로고
    • Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma
    • Dannenmann SR, Thielicke J, Stockli M, Matter C, von Boehmer L, Cecconi V, et al. Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma. Oncoimmunology 2013;2:e23562.
    • (2013) Oncoimmunology , vol.2 , pp. e23562
    • Dannenmann, S.R.1    Thielicke, J.2    Stockli, M.3    Matter, C.4    Von Boehmer, L.5    Cecconi, V.6
  • 44
    • 84939446621 scopus 로고    scopus 로고
    • CD25 identifies a subset of CD4+FoxP3-TIL that are exhausted yet prognostically favorable in human ovarian cancer
    • deLeeuw RJ, Kroeger DR, Kost SE, Chang PP, Webb JR, Nelson BH. CD25 identifies a subset of CD4+FoxP3-TIL that are exhausted yet prognostically favorable in human ovarian cancer. Cancer Immunol Res 2015;3:245-53.
    • (2015) Cancer Immunol Res , vol.3 , pp. 245-253
    • DeLeeuw, R.J.1    Kroeger, D.R.2    Kost, S.E.3    Chang, P.P.4    Webb, J.R.5    Nelson, B.H.6
  • 45
    • 84893876109 scopus 로고    scopus 로고
    • Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice
    • Deng L, Liang H, Burnette B, Beckett M, Darga T, Weichselbaum RR, et al. Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice. J Clin Invest 2014;124:687-95.
    • (2014) J Clin Invest , vol.124 , pp. 687-695
    • Deng, L.1    Liang, H.2    Burnette, B.3    Beckett, M.4    Darga, T.5    Weichselbaum, R.R.6
  • 46
    • 84907486895 scopus 로고    scopus 로고
    • Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockade
    • Dovedi SJ, Adlard AL, Lipowska-Bhalla G, McKenna C, Jones S, Cheadle EJ, et al. Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockade. Cancer Res 2014;74:5458-68.
    • (2014) Cancer Res , vol.74 , pp. 5458-5468
    • Dovedi, S.J.1    Adlard, A.L.2    Lipowska-Bhalla, G.3    McKenna, C.4    Jones, S.5    Cheadle, E.J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.